BETA Winter/Spring 2009

In this issue, HIV prevention advocates Emily Bass, Cindra Feuer, and Mitchell Warren discuss AIDS vaccine development—and why a vaccine is still needed and still possible. Liz Highleyman takes a look at nanotechnology as a promising new approach to antiretroviral drug delivery, and clinician Anne Monroe explains how diabetes, HIV, and HIV drugs interact, and how HIV positive diabetics can optimize their health. And HIV specialist Kathleen Clanon and HIV health advocate Nancy Halloran offer practical solutions and suggestions for getting the most from your medical care.

AIDS Vaccine Research and Advocacy: An Update

Is an AIDS vaccine necessary? Is an AIDS vaccine even possible? These questions have been constant companions in the search for a safe, effective, and affordable AIDS vaccine--search that dates almost from the beginning of the epidemic--but they came to the foreground in September 2007, when the STEP vaccine trial was halted. Read more...

Making the Most of Your Medical Visits

When you go to see your medical provider, do you sometimes leave frustrated or confused, with unanswered questions? Does your medical provider spend too much time on blood tests and labwork, and not enough time listening to your concerns? Do you feel rushed and unable to discuss what is really going on with your health? Read more...

HIV/AIDS and Diabetes: Minimizing Risk, Optimizing Care

Recent literature about diabetes and disorders of glucose metabolism in people with HIV/AIDS contains conflicting messages. Some studies indicate an increased risk of diabetes mellitus (generally referred to simply as “diabetes”) in people taking HAART, specifically protease inhibitors (PIs). Other studies indicate that nucleoside reverse transcriptase inhibitors (NRTIs) are the culprit. Read more...

News Briefs

The 17th International AIDS Conference (AIDS 2008)—the world’s largest meeting focused on all aspects of the epidemic—took place August 3–8 in Mexico City. The 48th Annual Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC) this year was held jointly with the Infectious Diseases Society of America (IDSA) annual meeting on October 25–28 in Washington, DC. Read more...

Drug Watch: Nanotechnology for Antiretroviral Drug Delivery

As people with HIV live longer and require ongoing antiretroviral therapy for years or decades, the ease and tolerability of treatment assumes added importance. Recent therapeutic advances that have contributed to increased convenience and improved adherence include ritonavir (Norvir) “boosting,” once-daily dosing, and fixed-dose coformulations that combine multiple drugs in a single pill. Read more...

Women and HIV: Microbicide Development: Positive Women’s Concerns

Formulated as anti-HIV gels, creams, or films, or loaded into vaginal rings or onto barrier devices such as diaphragms, microbicides are currently being developed to provide an HIV prevention tool that women can control directly and use without necessarily informing their sex partners. Rectal applications are also in the early stages of development to help reduce HIV risk for women and men who have anal sex. Read more...

Open Clinical Trials

Below is a selected list of currently enrolling clinical trials gathered from various sources. The federal government’s AIDSinfo website includes a clinical trials section that features an introduction to HIV/ AIDS research and study listings from the National Institutes of Health’s database. AIDSinfo also offers personalized advice about clinical trial participation via email (, an interactive website (, and a toll-free telephone service (800-448-0440, international 301-315- 2816). Read more...

HAART Chart - Approved Antiretroviral Drugs


Get Adobe Reader

Having trouble reading these articles?

These articles are published as PDFs, for which you need some version of the Adobe Reader. You can click on the image to the right to download it if you don't have it.

If your browser won't let you open those links, please let us know.

Keep Exploring

Get Tested

The best way to fight HIV is to know your status. A simple test can determine if you are infected with the virus.

Learn more...

Our Work

Our diverse programs help thousands of people every year. From testing to prevention to care, our services assist communities where need is greatest.

See what we're doing...

Our Blog

Keep up with what's happening now in the fight against HIV from foundation experts.

Check it out...


Contact Us

415/487-8079 (FAX)

San Francisco AIDS Foundation

1035 Market St
Suite 400
San Francisco CA